Insider · CIK 0001296771
Freund John Gordon
Reports to the SEC for 14 companies · SANTA CLARA, CA
Transactions
50
Companies
14
Filings
15
CIK
0001296771
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-04 | SIBNSI-BONE, Inc.A Award | — |
| 2026-05-18 | COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale | −$681 |
| 2026-05-15 | COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale | −$143K |
| 2026-05-15 | COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion | — |
| 2026-05-15 | COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion | +$143K |
| 2026-05-14 | COLLCOLLEGIUM PHARMACEUTICAL, INCA Award | — |
| 2025-08-08 | SIBNSI-BONE, Inc.S Sale | −$194K |
| 2025-08-08 | COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale | −$401K |
| 2025-06-09 | COLLCOLLEGIUM PHARMACEUTICAL, INCM Exercise/Conversion | +$202K |
| 2025-06-09 | COLLCOLLEGIUM PHARMACEUTICAL, INCS Sale | −$202K |
| 2025-06-09 | COLLCOLLEGIUM PHARMACEUTICAL, INC · Stock Option (Right to Purchase)M Exercise/Conversion | — |
| 2025-06-05 | SIBNSI-BONE, Inc.A Award | — |
| 2025-05-15 | COLLCOLLEGIUM PHARMACEUTICAL, INCA Award | — |
| 2024-06-26 | SIBNSI-BONE, Inc.A Award | — |
| 2024-06-06 | STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award | — |
| 2024-05-16 | COLLCOLLEGIUM PHARMACEUTICAL, INCA Award | — |
| 2023-08-09 | SIBNSI-BONE, Inc.S Sale | −$616K |
| 2023-06-09 | SIBNSI-BONE, Inc.A Award | — |
| 2023-06-08 | STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award | — |
| 2023-05-18 | COLLCOLLEGIUM PHARMACEUTICAL, INCA Award | — |
| 2022-06-16 | SIBNSI-BONE, Inc.A Award | — |
| 2022-06-06 | STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award | — |
| 2022-05-19 | COLLCOLLEGIUM PHARMACEUTICAL, INCA Award | — |
| 2021-06-16 | SIBNSI-BONE, Inc.S Sale | −$395K |
| 2021-06-15 | SIBNSI-BONE, Inc.S Sale | −$669K |
| 2021-06-14 | SIBNSI-BONE, Inc.S Sale | −$563K |
| 2021-06-10 | SIBNSI-BONE, Inc.A Award | — |
| 2021-06-03 | STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award | — |
| 2021-05-28 | SIBNSI-BONE, Inc.S Sale | −$1.36M |
| 2021-05-27 | SIBNSI-BONE, Inc.S Sale | −$816K |
| 2021-05-26 | SIBNSI-BONE, Inc.S Sale | −$546K |
| 2021-05-25 | SIBNSI-BONE, Inc.S Sale | −$55.2K |
| 2021-05-24 | SIBNSI-BONE, Inc.S Sale | −$6,552 |
| 2021-05-24 | SIBNSI-BONE, Inc.S Sale | −$1.65M |
| 2021-05-20 | COLLCOLLEGIUM PHARMACEUTICAL, INCA Award | — |
| 2021-03-17 | SIBNSI-BONE, Inc.S Sale | −$18.2M |
| 2021-03-17 | SIBNSI-BONE, Inc.S Sale | −$2.09M |
| 2021-03-16 | SIBNSI-BONE, Inc.S Sale | −$1.67M |
| 2021-03-15 | SIBNSI-BONE, Inc.S Sale | −$2.5M |
| 2021-03-12 | SIBNSI-BONE, Inc.S Sale | −$2.86M |
| 2021-03-11 | SIBNSI-BONE, Inc.S Sale | −$1.98M |
| 2020-12-10 | STROSUTRO BIOPHARMA, INC.J Other | — |
| 2020-12-10 | STROSUTRO BIOPHARMA, INC.J Other | — |
| 2020-12-03 | SIBNSI-BONE, Inc.S Sale | −$1.12M |
| 2020-12-02 | SIBNSI-BONE, Inc.S Sale | −$2.33M |
| 2020-11-09 | STROSUTRO BIOPHARMA, INC.J Other | — |
| 2020-11-09 | STROSUTRO BIOPHARMA, INC.J Other | — |
| 2020-10-19 | SIBNSI-BONE, Inc.S Sale | −$4.18M |
| 2020-09-18 | STROSUTRO BIOPHARMA, INC.S Sale | −$4.8M |
| 2020-09-11 | STROSUTRO BIOPHARMA, INC.S Sale | −$5M |
Recent filings
- 4Freund John Gordon0001296771-26-000005SEC(opens sec.gov)
- 4Freund John Gordon0001296771-26-000004SEC(opens sec.gov)
- 4Freund John Gordon0001296771-26-000002SEC(opens sec.gov)
- 4Freund John Gordon0001062993-25-014202SEC(opens sec.gov)
- 4Freund John Gordon0001562180-25-005706SEC(opens sec.gov)
- 4Freund John Gordon0001062993-25-011425SEC(opens sec.gov)
- 4Freund John Gordon0001562180-25-004608SEC(opens sec.gov)
- 4Freund John Gordon0001062993-25-009806SEC(opens sec.gov)
- 4Freund John Gordon0001562180-24-005334SEC(opens sec.gov)
- 4Freund John Gordon0001415889-24-016209SEC(opens sec.gov)
- 4Freund John Gordon0001062993-24-010540SEC(opens sec.gov)
- 4Freund John Gordon0001562180-23-006298SEC(opens sec.gov)
- 4Freund John Gordon0001562180-23-005109SEC(opens sec.gov)
- 4Freund John Gordon0001209191-23-036467SEC(opens sec.gov)
- 4Freund John Gordon0001062993-23-011817SEC(opens sec.gov)
Companies
- COLLEGIUM PHARMACEUTICAL, INCDirectorCOLL
- CONCERT PHARMACEUTICALS, INC.Director, 10% Owner
- Dicerna Pharmaceuticals Incfomer 10% holder
- HANSEN MEDICAL INCDirector
- MAKO Surgical Corp.Director
- MAP Pharmaceuticals, Inc.Director, 10% Owner
- Protara Therapeutics, Inc.DirectorTARA
- SI-BONE, Inc.DirectorSIBN
- Sirtris Pharmaceuticals, Inc.Director
- SUTRO BIOPHARMA, INC.DirectorSTRO
- TALPHERA, INC.10% OwnerTLPH
- Targanta Therapeutics Corp.10% Owner
- TETRAPHASE PHARMACEUTICALS INCDirector
- XENOPORT INCDirector
Address
471 EL CAMINO REAL SUITE 101
SANTA CLARA, CA, 95050